Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells

The development of a substance or inhibitor-based treatment strategy for the prevention of aortic valve stenosis is a challenge and a main focus of medical research in this area. One strategy may be to use the tankyrase inhibitor XAV-939, which leads to Axin stabilisation and subsequent destruction...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Dittfeld, Claudia, Reimann, Gabriel, Mieting, Alice, Büttner, Petra, Jannasch, Anett, Plötze, Katrin, Steiner, Gerald, Tugtekin, Sems Malte, Matschke, Klaus
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286025/
https://ncbi.nlm.nih.gov/pubmed/30532256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0208774
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia